Quantcast

US Drug Watchdog Initiates New National Outreach Program Designed to Discover if Diabetics Now Living with Bladder Cancer Were Also Using the Diabetes Drug Called Actos

December 19, 2011

The US Drug Watchdog says, “No one would ever consider the possibility of a drug used for diabetes could also be related to elevated cases of bladder cancer. Unfortunately, the use of Actos for diabetes, and an elevated chance of bladder cancer could to be related. We need the help of loved ones, or family members of diabetics, who now have bladder cancer, to ask if the diabetic was using, or has also used the drug called Actos. There appears to be a correlation between US diabetics, bladder cancer, and the drug called Actos, and we want to identify every possible victim.” According to the AP, “The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication.” The US Drug Watchdog says, “We want to hear from any user of the diabetes medication called Actos, if they have developed bladder cancer. If after using Actos you, or a loved one developed bladder cancer please call our group immediately at 866-714-6466.” http://USDrugWatchdog.Com

(PRWEB) December 19, 2011

The US Drug Watchdog says, “We do not think the average bladder cancer victim, who was also a diabetic would ever consider a drug for diabetics could have been a contributing factor for bladder cancer, so we are urging loved ones, or family members to ask the question-were you using Actos before being diagnosed with bladder cancer? There may be a elevated incidence of bladder cancer for users of the diabetes drug called Actos, and we want to identify every US victim, in the hopes we can get them some meaningful help.” Actos is a member of a class of drugs known as thiazolidinediones, which have been linked to bladder cancer. Actos side effects include increased risk of congestive heart failure, and an increased risk for bladder cancer. According to the AP, “The US FDA has also issued a warning about Actos, and bladder cancer. Both Germany and France have suspended sales of Actos. The Actos suspension is effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication.” The US Drug Watchdog says, “We want to identify any user of the diabetes drug called Actos, if they have developed bladder cancer, and we think we will need the help of family members, and loved ones to get these victims identified.” For more information please call the US Drug Watchdog anytime at 866-714-6466, or contact the group via their web site at http://USDrugWatchdog.Com

The US Drug Watchdog says, “One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug’s use. If you have a friend, or loved one, who was, or is using the diabetes drug called Actos, who has developed bladder cancer, please have them call us at 866-714-6466.” http://USDrugWatchdog.Com

Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/12/prweb9050997.htm


Source: prweb



comments powered by Disqus